Furthermore, accumulating evidence suggests that GPER-mediated estrogen signaling may be tumor suppressive, including some non-sex hormone-related cancers such as hepatocellular carcinoma [21], colon cancer [22], and pancreatic ductal adenocarcinoma [23]. The gene discussed is GPER1; the disease is neoplasm.